Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-20-016714
Filing Date
2020-04-14
Accepted
2020-04-14 17:00:30
Documents
7
Period of Report
2020-06-05
Effectiveness Date
2020-04-14

Document Format Files

Seq Description Document Type Size
1 DEF 14A gern-def14a_20200605.htm DEF 14A 3062371
2 GRAPHIC g5mkwsjdz2fw000006.jpg GRAPHIC 2641
3 GRAPHIC g5mkwsjdz2fw000003.jpg GRAPHIC 1520
4 GRAPHIC g5mkwsjdz2fw000001.jpg GRAPHIC 2149
5 GRAPHIC g5mkwsjdz2fw000004.jpg GRAPHIC 2353
6 GRAPHIC g5mkwsjdz2fw000002.jpg GRAPHIC 2870
7 GRAPHIC g5mkwsjdz2fw000005.jpg GRAPHIC 2078
  Complete submission text file 0001564590-20-016714.txt   3083208
Mailing Address 149 COMMONWEALTH DRIVE SUITE 2070 MENLO PARK CA 94025
Business Address 149 COMMONWEALTH DRIVE SUITE 2070 MENLO PARK CA 94025 6504737700
GERON CORP (Filer) CIK: 0000886744 (see all company filings)

EIN.: 752287752 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-20859 | Film No.: 20791815
SIC: 2834 Pharmaceutical Preparations